NOVARTIS AG

NOVN
Delayed Quote. Delayed  - 12/04 04:21:37 am
80.82CHF -0.12%

Turn to zoom
Prev.80.9200
Open80.4000
High81.0400
Low80.4000
Volume573 474
Latest news
2d ago
4d ago
6d ago
7d ago
Chart NOVARTIS AG
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishNeutralNeutral
Resistance82,386,895,6
Spread/Res.-1,6%-6,8%-15%
Spread/Supp.5,9%14%14%
Support76,471,171,0
Financials
Sales 2020 49 423 M - -
Net income 2020 8 322 M - -
Net Debt 2020 19 271 M - -
P/E ratio 2020 24,9x
Yield 2020 3,46%
Capitalization 206 B 205 B -
EV / Sales 2020 4,55x
EV / Sales 2021 4,19x
Nbr of Employees 110 000
Free-Float 86,9%
Company
Novartis is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- pharmaceutical products (79.5%): used to treat cardiovascular, respiratory, and dermatological diseases, gastrointestinal...

>> Read more
Sector :
Pharmaceuticals - NEC
Calendar :
2020-12-02 Presentation
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 105,85 $
Last Close Price 91,51 $
Spread / Highest target 53,9%
Spread / Average Target 15,7%
Spread / Lowest Target -29,3%